Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1920 ARTÍCULOS , VIENDO DEL 1711 AL 1725

Anti-amyloid antibody treatments for Alzheimer's disease

Perneczky R, Dom G, Chan A, Falkai P, Bassetti C.

Eur J Neurol. 2024 Feb;31(2):e16049. doi: 10.1111/ene.16049. Epub 2023 Sep 11.

The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022

Veitch DP, Weiner MW, Miller M, Aisen PS, Ashford MA, Beckett LA, Green RC, Harvey D, Jack CR Jr, Jagust W, Landau SM, Morris JC, Nho KT, Nosheny R, Okonkwo O, Perrin RJ, Petersen RC, Rivera Mindt M, Saykin A, Shaw LM, Toga AW, Tosun D; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2024 Jan;20(1):652-694. doi: 10.1002/alz.13449. Epub 2023 Sep 12.

Investigation of sex differences in mutation carriers of the Dominantly Inherited Alzheimer Network

Wagemann O, Li Y, Hassenstab J, Aschenbrenner AJ, McKay NS, Gordon BA, Benzinger TLS, Xiong C, Cruchaga C, Renton AE, Perrin RJ, Berman SB, Chhatwal JP, Farlow MR, Day GS, Ikeuchi T, Jucker M, Lopera F, Mori H, Noble JM, Sánchez-Valle R, Schofield PR, Morris JC, Daniels A, Levin J, Bateman RJ, McDade E, Llibre-Guerra JJ; Dominantly Inherited Alzheimer Network.

Alzheimers Dement. 2024 Jan;20(1):47-62. doi: 10.1002/alz.13460. Epub 2023 Sep 23.

The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partners Scientific Board (PPSB)

Albala B, Appelmans E, Burress R, De Santi S, Devins T, Klein G, Logovinsky V, Novak GP, Ribeiro K, Schmidt ME, Schwarz AJ, Scott D, Shcherbinin S, Siemers E, Travaglia A, Weber CJ, White L, Wolf-Rodda J, Vasanthakumar A.

Alzheimers Dement. 2024 Jan;20(1):695-708. doi: 10.1002/alz.13483. Epub 2023 Sep 29.

Exosomes in multiple sclerosis and Alzheimer's disease - Adversary and ally

Tang N.

Biomed J. 2024 Oct;47(5):100665. doi: 10.1016/j.bj.2023.100665. Epub 2023 Sep 29.

Neprilysin inhibitors and risk of Alzheimer's disease: A future perspective

Ali NH, Al-Kuraishy HM, Al-Gareeb AI, Alnaaim SA, Alexiou A, Papadakis M, Khalifa AA, Saad HM, Batiha GE.

J Cell Mol Med. 2024 Jan;28(2):e17993. doi: 10.1111/jcmm.17993. Epub 2023 Oct 17.

Advances in targeted tracking and detection of soluble amyloid-β aggregates as a biomarker of Alzheimer's disease

Gao H, Chen J, Huang Y, Zhao R.

Talanta. 2024 Feb 1;268(Pt 1):125311. doi: 10.1016/j.talanta.2023.125311. Epub 2023 Oct 14.

Comparative methods for quantifying plasma biomarkers in Alzheimer's disease: Implications for the next frontier in cerebral amyloid angiopathy diagnostics

Muir RT, Ismail Z, Black SE, Smith EE.

Alzheimers Dement. 2024 Feb;20(2):1436-1458. doi: 10.1002/alz.13510. Epub 2023 Oct 31.

Comparison of CSF and plasma NfL and pNfH for Alzheimer's disease diagnosis: a memory clinic study

Vrillon A, Ashton NJ, Karikari TK, Götze K, Cognat E, Dumurgier J, Lilamand M, Zetterberg H, Blennow K, Paquet C.

J Neurol. 2024 Mar;271(3):1297-1310. doi: 10.1007/s00415-023-12066-6. Epub 2023 Nov 11.

Innovative SALDI mass spectrometry analysis for Alzheimer's disease synthetic peptides detection

Cournut A, Moustiez P, Coffinier Y, Enjalbal C, Bich C.

Talanta. 2024 Feb 1;268(Pt 2):125357. doi: 10.1016/j.talanta.2023.125357. Epub 2023 Nov 2.

Correlations between insulin-degrading enzyme and metabolic markers in patients diagnosed with type 2 diabetes, Alzheimer's disease, and healthy controls: a comparative study

Kullenberg H, Rossen J, Johansson UB, Hagströmer M, Nyström T, Kumlin M, Svedberg MM.

Endocrine. 2024 May;84(2):450-458. doi: 10.1007/s12020-023-03603-4. Epub 2023 Nov 18.

Clusterin is a Potential Therapeutic Target in Alzheimer's Disease

Palihati N, Tang Y, Yin Y, Yu D, Liu G, Quan Z, Ni J, Yan Y, Qing H.

Mol Neurobiol. 2024 Jul;61(7):3836-3850. doi: 10.1007/s12035-023-03801-1. Epub 2023 Nov 29.

Associations between Alzheimer's disease biomarkers and postoperative delirium or cognitive dysfunction: A meta-analysis and trial sequential analysis of prospective clinical trials

Geng J, Zhang Y, Chen H, Shi H, Wu Z, Chen J, Luo F.

Eur J Anaesthesiol. 2024 Mar 1;41(3):234-244. doi: 10.1097/EJA.0000000000001933. Epub 2023 Dec 1.

Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Alzheimer's disease

Abdelmaksoud NM, Sallam AM, Abulsoud AI, El-Dakroury WA, Abdel Mageed SS, Al-Noshokaty TM, Elrebehy MA, Elshaer SS, Mahmoud NA, Fathi D, Rizk NI, Elballal MS, Mohammed OA, Abdel-Reheim MA, Zaki MB, Saber S, Doghish AS.

Pathol Res Pract. 2024 Jan;253:155007. doi: 10.1016/j.prp.2023.155007. Epub 2023 Dec 4.

Harmonization of CSF and imaging biomarkers in Alzheimer's disease: Need and practical applications for genetics studies and preclinical classification

Timsina J, Ali M, Do A, Wang L, Western D, Sung YJ, Cruchaga C.

Neurobiol Dis. 2024 Jan;190:106373. doi: 10.1016/j.nbd.2023.106373. Epub 2023 Dec 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias